Skip to content

Cerebral Oxygen Saturation Monitoring During Optimum Cord Management in Preterm Infants

Cerebral Oxygen Saturation Monitoring During Optimum Cord Management in Preterm (COSMIC Pilot Study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06526091
Acronym
COSMIC
Enrollment
40
Registered
2024-07-29
Start date
2023-02-15
Completion date
2024-10-01
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-Term

Brief summary

This study will assess the feasibilty measuring cerebral oxygen saturations using a Near Infrared Spectroscopy (NIRS) monitor immediately after delivery of preterm infants. The investigators aim to evaluate the effects of optimum cord management on cerebral oxygenation in this cohort

Detailed description

Optimal cord management is defined by delaying clamping of the umbilical cord for 1 minute after delivery and is recommend in all neonates, regardless of gestational age. Transfusion of blood from placenta to baby in this minute enables smooth cardiovascular transition and stable cerebral perfusion. Preterm infants are at increased risk of haemodynamic instability and brain injury if the cord is clamped too early. It remains unclear what the optimum time is to clamp the cord in preterm infants, and it is likely different for each baby. Current monitoring of heart rate and peripheral oxygen saturations does not correlate well with oxygen delivery to the brain. Near infrared spectroscopy (NIRS) is a non-invasive method of measuring regional cerebral oxygenation saturations. NIRS may be a helpful monitoring tool to guide optimum timing of cord clamping in preterm infants. This study aims to assess the feasibility of using the INVOS 5100 NIRS monitor immediately after delivery in preterm infants born before 34 weeks gestational age. The investigators aim to assess if they can generate meaningful data on brain oxygen levels in the first few minutes of life. The secondary objectives are to use this data to describe the changes in heart rate, peripheral oxygen and cerebral oxygen saturations during placental transfusion and cord clamping. The investigators will use the INVOS device to measure cerebral oxygenation immediately after delivery, during placental transfusion and cord clamping. We will assess the feasibility of the INVOS device for this purpose. We will use the INVOS data and routinely collected data at delivery to evaluate the effect of optimum cord management on cerebral perfusion, heart rate and peripheral oxygen saturations.

Interventions

OTHERCerebral NIRS monitoring at delivery

Application of cerebral NIRS monitoring immediately after delivery and during optimum cord management

Sponsors

Imperial College Healthcare NHS Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Minutes to 24 Hours

Inclusion criteria

* All babies eligible for optimum cord management born before 34 completed weeks gestational age * Parental consent

Exclusion criteria

* Multiple pregnancies * Infants for whom resuscitation at birth is not appropriate * Antenatal or immediate postnatal diagnosis of severe congenital anomaly * Infants with complex congenital cardiac disease

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of regional cerebral saturation (rSO2 in %) monitoring using NIRS during optimum cord2 yearsFeasibility of regional cerebral saturation (rSO2 in %) monitoring using NIRS during optimum cord management in preterm infants

Secondary

MeasureTime frameDescription
Arterial saturation (SaO2 in %) monitoring2 yearsEvaluating the effect of optimum cord management on SaO2
Oxygenation (FiO2 in %) during stabilisation2 yearsEvaluating the effect of preterm stabilisation including optimum cord management on FiO2 (%)

Countries

United Kingdom

Contacts

Primary ContactJayanta Banerjee, MD (Res)
jayanta.banerjee@nhs.net07771826045
Backup ContactLaura Edgar, MBBS
l.edgar@nhs.net07747034477

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026